🇺🇸 FDA
Patent

US 8263747

Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins

granted A61KA61K2039/505

Quick answer

US patent 8263747 (Therapeutic monoclonal antibodies that neutralize botulinum neurotoxins) held by The Regents of the University of California expires Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Sep 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K2039/505